Percutaneous left atrial appendage occlusion versus oral anticoagulation in atrial fibrillation: A pragmatic meta-analysis of randomized trials within the DOAC era. [PDF]
Kuniyoshi GM +5 more
europepmc +1 more source
Temporal Trends in Anticoagulant Prescribing in Patients with Atrial Fibrillation According to Prior Ischemic Stroke or Transient Ischemic Attack: Insights from the CRAFT Registry. [PDF]
Bednarski J +6 more
europepmc +1 more source
Left atrial appendage occlusion: an alternative to anticoagulation in atrial fibrillation. [PDF]
Messaoudi Y +4 more
europepmc +1 more source
Background. Heavy menstrual bleeding (HMB) is a primary side effect in women starting direct oral anticoagulants (DOACs). Defining predictors and management protocols for DOAC-related HMB remains a clinical challenge. Aims.
Maria Abbattista
doaj
Locked MEDLINE/PubMed search strategy archive for a systematic review and meta-analysis of anticoagulation versus clinical surveillance in patients with active cancer and isolated subsegmental pulmonary embolism in the DOAC era.
Thomas Christian Landry
core
DOAC — not for everyone, and sometimes at different dose
openaire +2 more sources
Cerebral Microbleeds, Anemia, and Estimated Net Benefit of DOACs versus Warfarin in Older Atrial Fibrillation: A Single-Center MRI-Selected Cohort. [PDF]
Ma J +5 more
europepmc +1 more source
Optimization of direct oral anticoagulant prescribing in primary care: a pharmacotherapeutic review in real-world clinical practice and therapeutic efficiency. [PDF]
Gotanegra Guzmán N +7 more
europepmc +1 more source
Risk factors of major bleeding associated with direct oral anticoagulant treatment in patients with venous thromboembolism: a systematic review and meta-analysis. [PDF]
Zhan H, Ma F, Zhou J, Zhang J.
europepmc +1 more source
Antithrombotic Management after Successful Catheter Ablation for Atrial Fibrillation: Meta-analysis of the ALONE-AF and OCEAN Trials. [PDF]
Cheng WH +6 more
europepmc +1 more source

